Form 4 for ARQT Arcutis Biotherapeutics, Inc.
Accepted 2024-06-06 00:00:00 ET · period of report 2024-06-04 · accession 0001787306-24-000087 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-06-06 | 2024-06-04 | ARQT | Welgus Howard G. | Dir | S - Sale+OE | $8.01 | -10.0K | 176.7K | -5% | -$80.1K |
| DM | 2024-06-06 | 2024-06-04 | ARQT | Welgus Howard G. | Dir | M - OptEx | $1.68 | +10.0K | 173.7K | +6% | +$16.8K |
| DM | 2024-06-06 | 2024-06-04 | ARQT | Welgus Howard G. | Dir | M - OptEx | $0.00 | -10.0K | 5,681 | -64% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-06-04 | S | D | 6,458 | $8.01 | 170,200 | D | — | — | (F1) The transaction was executed in multiple trades in prices ranging from $8.00 to $8.155, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| 2 | Common | Common Stock | 2024-06-04 | S | D | 3,542 | $8.00 | 176,658 | D | — | — | |
| 3 | Common | Common Stock | 2024-06-04 | M | A | 6,458 | $1.68 | 180,200 | D | — | — | |
| 4 | Common | Common Stock | 2024-06-04 | M | A | 3,542 | $1.68 | 173,742 | D | — | — | |
| 5 | Derivative | Stock Option (right to buy) | 2024-06-04 | M | D | 6,458 | $0.00 | 0 | D | $1.68 · — to 2029-03-13 | 6,458 Common Stock | (F3) The option is fully vested. |
| 6 | Derivative | Stock Option (right to buy) | 2024-06-04 | M | D | 3,542 | $0.00 | 5,681 | D | $1.68 · — to 2029-03-13 | 3,542 Common Stock | (F3) The option is fully vested. |